CLVLF Projected Dividend Yield
Ord/Clinuvel Pharmaceuticals Ltd. ( OTCBB : CLVLF )Clinuvel Pharmaceuticals is a biopharmaceutical company focussed on developing and delivering treatments for patients with a range of genetic and skin disorders. Co.'s research and development is focussed on treatments for patient populations with a clinical need for photoprotection and repigmentation. Co. is focused on developing and commercialising SCENESSE® as a preventative therapy to photo-protect patients with erythropoietic protoporphyria. Co. is also focused on developing and commercializing SCENESSE® as a combination therapy with narrowband ultraviolet B phototherapy for patients with vitiligo. Co. has operations in Europe, Singapore and the United States. 18 YEAR PERFORMANCE RESULTS |
|
CLVLF Dividend History Detail CLVLF Dividend News CLVLF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend Amount (AUD) |
2025 |
N/A |
N/A |
Sep 05, 2025 |
Sep 19, 2025 |
0.0500 |
2025 Total: |
0.0500 |
||||
2024 |
N/A |
N/A |
Sep 06, 2024 |
Sep 20, 2024 |
0.0500 |
2024 Total: |
0.0500 |
||||
2023 |
N/A |
N/A |
Sep 06, 2023 |
Sep 20, 2023 |
0.0500 |
2023 Total: |
0.0500 |
||||
2022 |
N/A |
N/A |
Sep 07, 2022 |
Sep 21, 2022 |
0.0400 |
2022 Total: |
0.0400 |
||||
2021 |
N/A |
N/A |
Sep 03, 2021 |
Sep 17, 2021 |
0.0250 |
2021 Total: |
0.0250 |


